Results: Science Environmental Protection Co., Ltd. Beat Earnings Expectations And Analysts Now Have New Forecasts
It's been a pretty great week for Science Environmental Protection Co., Ltd. (SHSE:688480) shareholders, with its shares surging 10% to CN¥34.00 in the week since its latest annual results. It l
Science Environmental Protection Co., Ltd.'s (SHSE:688480) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Most readers would already be aware that Science Environmental Protection's (SHSE:688480) stock increased significantly by 15% over the past week. Given that stock prices are usually aligned with a
Synes (688480.SH) reported 2023 annual results, net profit of 90,3279 million yuan, a year-on-year increase of 36.39%
Syns (688480.SH) released its 2023 annual report. The company achieved operating income of 8.0 during the reporting period...
Syns (688480.SH) grants 168,500 restricted shares at an award price of 13.93 yuan/share
Zhitong Finance App News, Sains (688480.SH) issued an announcement. The board of directors of the company believes that the conditions for awarding the 2023 restricted stock incentive plan have been fulfilled. According to the authorization of the company's 3rd Extraordinary General Meeting of Shareholders in 2023, the board of directors agreed to determine April 2, 2024 as the reservation grant date. A total of 168,500 restricted shares were awarded to 14 incentive recipients who met the grant conditions, at a grant price of 13.93 yuan/share.
Science Environmental Protection Co., Ltd.'s (SHSE:688480) P/E Is Still On The Mark Following 25% Share Price Bounce
Those holding Science Environmental Protection Co., Ltd. (SHSE:688480) shares would be relieved that the share price has rebounded 25% in the last thirty days, but it needs to keep going to repair the
Syns (688480.SH) performance report: 2023 net profit of 93.244 million yuan, a year-on-year increase of 40.79%
GLONGHUI, Feb. 23 | SAINCE (688480.SH) announced the 2023 Annual Results Report. During the reporting period, the company achieved operating income of 807.926 million yuan, a year-on-year increase of 47.39%; achieved net profit attributable to owners of the parent company of 93.244 million yuan, an increase of 40.79% year on year; realized net profit attributable to owners of the parent company after deducting non-recurring profit and loss of 75.970 million yuan, an increase of 36.27% year on year.
Returns On Capital At Science Environmental Protection (SHSE:688480) Have Stalled
To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd like to see a company investing more capital into its business and ideally the
Sainz (688480.SH): Sales of Zijin Pharmaceuticals are less affected by seasonal fluctuations
GLONGHUI, January 17 | When receiving research from institutional investors, Sains (688480.SH) recently said that sales of Zijin Pharmaceuticals are less affected by seasonal fluctuations. They mainly sell products in batches. There are phased sales, and revenue fluctuations are mainly delivery issues. If some customers increase production capacity and the amount required for initial production is high, it will lead to higher sales. The increase in sales in the fourth quarter of 2023 is mainly due to the large number of orders placed during the current period due to the fact that some major customers have reached the replenishment cycle.
Syns (688480.SH): Zijin Pharmaceutical currently accounts for less than 30% of domestic sales, and the market is mainly overseas
Gelonghui, January 17, 丨 While receiving research from institutional investors, Ge Longhui (688480.SH) recently said that Zijin Pharmaceutical currently accounts for less than 30% of domestic sales, and the market is mainly overseas. At present, the domestic market is relatively saturated, and overseas markets can increase their own market share by competing with BASF and others through product cost advantages and service advantages. Zijin Pharmaceuticals accounts for a relatively low sales volume in the Chilean market, mainly in the Democratic Republic of the Congo (DRC), and accounts for about 1/2 of Zijin Pharmaceuticals' current revenue.
Syns (688480.SH) plans to acquire 61% of Zijin Pharmaceutical's shares to hold all of its shares
Syns (688480.SH) announced that the company plans to use its own capital of 183 million yuan to acquire participating shareholders...
Syns (688480.SH): The company's equity incentive target for next year is 1.1 billion dollars in revenue
On December 29, GLONGHUI (688480.SH) said in an interview with specific targets that the company's equity incentive target next year is 1.1 billion dollars in revenue, and the company will make every effort to achieve higher goals and give back to investors.
Syns (688480.SH): The company's new energy business is growing
GLONGHUI, December 29 | When surveyed by specific subjects, Sains (688480.SH) said that the company's new energy business is growing, but due to the impact of its overall market, it falls slightly short of expectations.
Syns (688480.SH): Overseas orders have increased significantly compared to last year
GLONGHUI, December 29 | When surveyed by specific targets, Sains (688480.SH) said that there was a significant increase in overseas orders compared to last year, mainly reflected in Serbian subsidiaries and Africa; Australian companies mainly provide technical services and are currently still in the registration and team formation stage, and their market prospects are broad.
Syns (688480.SH): The company's integrated solution orders have increased significantly compared to the same period last year, and are basically delivered within one year
GLONGHUI, December 29 | When surveyed by specific targets, Sains (688480.SH) said that the company's integrated solution orders increased significantly compared with the same period last year, and were basically delivered within one year.
Synes (688480.SH) issued an advance increase. Net profit for 2023 is expected to be 80 million yuan to 86 million yuan, up 20.8% to 29.86% year on year
Synes (688480.SH) disclosed the 2023 annual results forecast, and the company expects to achieve it in 2023...
Synes (688480.SH): Controlling shareholder Gao Weirong's cumulative holdings increased by 0.33%, and the implementation of the plan to increase share holdings has been completed
Glonghui (688480.SH) announced that as of December 18, 2023, Mr. Gao Weirong, the controlling shareholder of the company, has accumulated 311,685 shares in the Shanghai Stock Exchange trading system through centralized bidding and bulk trading, accounting for 0.33% of the company's total share capital. The total increase amount is RMB 11.9992 million, which has exceeded the lower limit of the current holdings increase plan, and the implementation of this increase plan has been completed.
The controlling shareholders of 688480.SH increased their holdings of the company by a total of 134,000 shares
Synes (688480.SH) announced that from October 31 to December 8, 2023, the company's holdings...
Synes (688480.SH): 2012 million restricted shares will be listed and distributed on December 7, accounting for 21.22% of the total share capital
Synes (688480.SH) announced that the company has now lifted sales restrictions and applied for listing, and the number of shares for circulation is 201...
Synes (688480.SH): 21.907 million restricted shares will be listed and distributed from November 27
Synes (688480.SH) issued an announcement on the listing and circulation of some restricted shares in the initial public offering, which has now been lifted...
Insiders the Biggest Winners as Science Environmental Protection Co., Ltd.'s (SHSE:688480) Market Cap Rises to CN¥3.6b
Key Insights Significant insider control over Science Environmental Protection implies vested interests in company growth The top 3 shareholders own 53% of the company Analyst forecasts along wit
No Data